medigraphic.com
ISSN 0210-5187 (Electronic)

2012, Number 6

<< Back Next >>

Med Cutan Iber Lat Am 2012; 40 (6)

Update on primary focal hyperhidrosis

González FD, Pérez ON

Language: Spanish
References: 27
Page: 173-180
PDF size: 101.93 Kb.


ABSTRACT

Primary focal hyperhidrosis (PFH) is an idiopathic pathology that affects 2.8% of the population and causes strong impact on social life, and daily activities of patients with the disease. When you suspect that a patient may suffer primary focal hyperhidrosis must perform a carefully history and physical examination to exclude secondary causes of hyperhidrosis. Afterwards the affected area is delimited by the Minor test and we can evaluate the effects of the disease in the patient’s quality of life through a variety of test.
There are many effective treatments for PFH: topical treatments, iontophoresis, botulinum toxin injection, microwave, systemic treatments and surgical treatments. Each of these treatments has different characteristics, knowledge of these features will allow us to indicate to each patient the best treatment based on the severity, location and psychological impact of PFH and get a satisfactory outcome for both the patient and the physician.


REFERENCES

  1. Hoorens I, Ongenae K. Primary focal Hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol Venerealol 2012; 26: 1-8.

  2. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar Hyperhidrosis: evidence of genetic transmission. J Vasc Surg 2002; 35: 382-6.

  3. Solish N, Bertucci V, Dansereau A et al. A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 2007; 33: 908-23.

  4. Walling HW, Swick BL. Treatment Options for Hyperhidrosis. Am J Clin Dermatol 2011; 12: 285-95.

  5. Albornoz López R, Arias Rico R, Torres Degayón V, Gago Sánchez A. Formulación de glicopirrolato tópico en hiperhidrosis. Farm Hosp 2008; 32: 358-63.

  6. Kim WO, Kill HK, Yoon KB, Yoon DM. Topical glycopirrolate for patients with facial hyperhidrosis. Br J Dermatol 2008; 158: 1094-7.

  7. Callejas MA, Grimalt R. Glicopirrolato tópico en la hiperhidrosis craneofacial. Med Clin 2008: 131: 156-9.

  8. Kavanagh GM, Burns C, Aldridge RD. Topical glycopirrolate should not be overlooked in treatment of focal Hyperhidrosis. Br J Dermatol 2006; 155: 487.

  9. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin 1998;16: 863-9.

  10. Hashmanai M, Kopelman D, Assalia A. The treatment of primary palmar hyperhidrosis: a review. Surg Today 2000; 30: 211-8.

  11. Excel D, Dal Forno T. Type A Botulinum toxin in the upper aspect of the face. Clin Dermatol 2003; 21: 488-97.

  12. Johnson JE, O’Shaughnessy KF, Kim S. Microwave Thermolysis of Sweat Glands. Lasers Surg Med 2012; 44: 20-5.

  13. Glaser DA, Coleman WP, Fan LK et al. A Randomized, Blinded Clinical Evaluation of a Novel Microwave Device for treating Axillary Hyperhidrosis: The Dermatologic Reduction in Underarm Perspiration Study. Dermatol Surg 2012; 38: 185-91.

  14. Tupker RA, Harmsze AM, Deneer VH. Oxybutynin therapy for generalized hyperhidrosis. Arch Dermatol 2006; 142: 1065- 6.

  15. Bajaj V, Langtry JA. Use of oral glycopyrronium bromide in hyperhidrosis. Br J Dermatol 2007; 157: 118-21.

  16. Walling HW. Systemic therapy for primary hyperhidrosis: a retrospective study of 59 patients treated with glycopyrrolate or clonidine. J Am Acad Dermatol 2012; 66: 387-92.

  17. Lee HH, Kim do W, Kim do W, Kim C. Efficacy of glycopyrrolate in primary hyperhidrosis patients. Korean J Pain 2012; 25: 28-32.

  18. Wolosker N, de Campos JR, Kauffman P, Puech-Leao P. A randomized placebo-controlled trial of oxybutinina for the inicial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 2012; 55: 1696-700.

  19. Mack GW, Shannon LM, Nadel ER. Influence of beta-adrenergic blockade on the control of sweating in humans. J Appl Physiol 1986; 61: 1701-5.

  20. Quraishy MS, Giddings AE. Treating hyperhidrosis. BMJ 1993; 306: 1221-2.

  21. Kotzareff A. Resection partielle de troné sympathetique cervical droit pour hyperhidrose unilaterale. Rev Med Suisse Romande 1920; 40: 111-3.

  22. Zacherl J, Huber ER, Imhof M et al. Longterm results of 630 thoracoscopic sympathicotomies for primary hyperhidrosis: the Vienna experience. Eur J Surg 1998; 580: 43-6.

  23. Togel B, Grève B, Raulin C. Current therapeutic strategies for hyperhidrosis: a review. Eur J Dermatol 2002; 12: 219-23.

  24. Rieger R, Loureiro MP, Pedevilla S et al. Endoscopie lumbar sympathectomy following thoracic sympathectomy in patients with palmo-plantar hyperhidrosis. World J Surg 2011; 35: 49-53.

  25. Licht PB, Jorgensen OD, Ladegaard L et al. Thoracoscopic sympathectomy for axillary hyperhidrosis: the influent of T4. Ann Thorac Surg 2005; 80: 455-459.

  26. Eisenach JH, Atkinson JLD, Fealey RD. Hyperhidrosis: evolving therapies for a wellestabhshed phenomenon. Mayo Clin Proc 2005; 80: 657-66.

  27. Callejas MA, Grimalt R, Cladellas E. Actualización en hiperhidrosis. Actas Dermosifiliogr 2010; 101: 110-8.




2020     |     www.medigraphic.com